Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan

Clinical trial NCT01318083 · COMPLETED

Trial details

NCT number: NCT01318083
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2008-08-01
Primary completion: 2009-04-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.